Neuronetics, Inc. develops medical devices that provide non-drug, non-invasive treatments for psychiatric disorders, focusing on major depressive disorder (MDD). Its primary product, NeuroStar® Advanced Therapy, utilizes transcranial magnetic stimulation (TMS) and is supported by extensive clinical evidence. The company serves a broad audience, including adults with MDD, and aims to expand its treatment capabilities and geographic reach. Neuronetics also offers sales and customer support to practices utilizing its technology.
- Website
- www.neuronetics.com
- Issuer profile
- All listings